NQSE:XETRA:XETRA-iShares NASDAQ 100 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 10.686

Change

+0.28 (+2.71)%

Market Cap

USD 0.35B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.34 (-0.66%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.73%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.19 (-0.69%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.20 (-0.71%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.35%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.34 (-0.23%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-0.58 (-0.41%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.27 (-0.61%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.68%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.56 (+0.71%)

USD 80.38B

ETFs Containing NQSE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.40% 49% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.40% 49% F 51% F
Trailing 12 Months  
Capital Gain 32.35% 90% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.35% 90% A- 89% A-
Trailing 5 Years  
Capital Gain 107.21% 98% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 107.21% 98% N/A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 19.54% 94% A 91% A-
Dividend Return 19.54% 94% A 90% A-
Total Return N/A 66% D+ 57% F
Risk Return Profile  
Volatility (Standard Deviation) 26.99% 13% F 24% F
Risk Adjusted Return 72.40% 89% A- 89% A-
Market Capitalization 0.35B 60% D- 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.